[Anti-proliferative and apoptotic effects of Lovastatin on K562 Erthromyloidy cancer cell line]
Journal of Gorgan University of Medical Sciences. 2017; 18 (4): 52-59
en Persa
| IMEMR
| ID: emr-189606
ABSTRACT
Background and Objective:
Lovastatin is a HMG-CoA reductase inhibitor and used for the treatment of hypercholesterolemia. Inhibition of HMG-CoA reductase results in inhibiting the activity of the Ras proto-oncogene that has mutations in most cancers. This study was done to determine the Anti-proliferative and apoptotic effects of Lovastatin on K562 Erthromyloidy cancer cell line
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Leucemia Mielógena Crónica BCR-ABL Positiva
/
Apoptosis
/
Células K562
/
Línea Celular Tumoral
Idioma:
Persa
Revista:
J. Gorgan Univ. Med. Sci.
Año:
2017
Similares
MEDLINE
...
LILACS
LIS